Shanghai Henlius Biotech, Inc.
HKEX:2696.HK
21.45 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||
| Net Income
| 569.578 | -693.887 | -956.739 | -993.541 | -874.81 | -500.22 | -379.997 |
| Depreciation & Amortization
| 359.233 | 277.603 | 200.176 | 135.776 | 82.499 | 42.968 | 26.584 |
| Deferred Income Tax
| 33.089 | 0 | 245.453 | 60.136 | 36.939 | -13.385 | -3.851 |
| Stock Based Compensation
| 2.587 | 12.517 | 48.417 | 35.731 | 97.117 | 71.686 | 127.878 |
| Change In Working Capital
| -21.106 | 1,100.685 | 511.131 | 115.664 | 152.994 | 302.388 | 40.403 |
| Accounts Receivables
| -283.769 | -161.406 | -99.702 | -340.94 | -28.309 | 13.079 | -13.9 |
| Inventory
| -22.336 | -340.64 | -91.708 | -53.727 | -100.225 | -0.252 | -1.239 |
| Accounts Payables
| 283.769 | 161.406 | 99.702 | 340.94 | 28.309 | 0 | 0 |
| Other Working Capital
| 1.23 | 1,441.325 | 602.839 | 169.391 | 253.219 | 302.64 | 41.642 |
| Other Non Cash Items
| 104.54 | 284.702 | 41.954 | 36.654 | 62.134 | 44.384 | 54.695 |
| Operating Cash Flow
| 1,047.921 | 981.62 | 90.392 | -609.58 | -443.127 | -52.179 | -134.288 |
| Investing Activities: | |||||||
| Investments In Property Plant And Equipment
| -1,011.444 | -1,365.292 | -1,131.193 | -1,512.522 | -1,132.925 | -735.375 | -471.662 |
| Acquisitions Net
| -15 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -120 | -550.61 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| -537.747 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 679.754 | 557.171 | -550.061 | 0.273 | -843.98 | -598.305 | -356.275 |
| Investing Cash Flow
| -1,004.437 | -1,358.731 | -1,681.254 | -1,512.249 | -1,132.925 | -735.375 | -471.662 |
| Financing Activities: | |||||||
| Debt Repayment
| -2,147.093 | -1,785.465 | -1,295.651 | -335.284 | -591.632 | -846.788 | -225 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 2,949.753 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -129.905 | 2,643.481 | 1,943.953 | 1,331.075 | 589.77 | 2,525.893 | 766.38 |
| Financing Cash Flow
| 144.431 | 858.016 | 648.302 | 995.791 | 2,947.891 | 1,679.105 | 541.38 |
| Other Information: | |||||||
| Effect Of Forex Changes On Cash
| 6.272 | 37.589 | -16.767 | -60.745 | -29.737 | 8.927 | -0.237 |
| Net Change In Cash
| 194.187 | 518.494 | -959.327 | -1,186.783 | 1,342.102 | 900.478 | -64.807 |
| Cash At End Of Period
| 867.663 | 673.476 | 154.982 | 1,114.309 | 2,301.092 | 958.99 | 58.512 |